Billiontoone (NASDAQ:BLLN) Stock Price Up 3.5% – What’s Next?

Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report) shares traded up 3.5% on Wednesday. The company traded as high as $98.11 and last traded at $97.71. Approximately 70,566 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 551,014 shares. The stock had previously closed at $94.44.

Analysts Set New Price Targets

BLLN has been the topic of a number of analyst reports. Weiss Ratings cut shares of Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research report on Thursday, October 8th. JPMorgan Chase & Co. cut their price target on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating for the company in a research report on Thursday, August 6th. Guggenheim raised their price objective on Billiontoone from $125.00 to $128.00 and gave the company a “buy” rating in a research note on Thursday, October 1st. Zacks Research raised Billiontoone from a “strong sell” rating to a “hold” rating in a research note on Friday, October 2nd. Finally, Canaccord Genuity Group initiated coverage on Billiontoone in a report on Wednesday, September 2nd. They issued a “buy” rating and a $120.00 price objective on the stock. Seven investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Billiontoone presently has an average rating of “Moderate Buy” and an average target price of $126.25.

Read Our Latest Stock Report on BLLN

Billiontoone Stock Performance

The stock has a market cap of $4.85 billion and a PE ratio of 139.83. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31. The business has a 50 day moving average price of $100.90 and a two-hundred day moving average price of $101.60.

Billiontoone (NASDAQ:BLLN – Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The firm had revenue of $109.45 million for the quarter. As a group, equities research analysts forecast that Billiontoone, Inc. will post 0.80 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, insider Thomas P. Lynch sold 35,112 shares of the business’s stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of $110.33, for a total transaction of $3,873,906.96. Following the transaction, the insider owned 700 shares in the company, valued at $77,231. The trade was a 98.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 32,500 shares of the business’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $136.95, for a total transaction of $4,450,875.00. Following the transaction, the chief executive officer owned 20,000 shares in the company, valued at $2,739,000. This represents a 61.90% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 238,025 shares of company stock worth $26,297,325. 50.22% of the stock is currently owned by corporate insiders.

Institutional Trading of Billiontoone

Large investors have recently bought and sold shares of the company. Wasatch Advisors LP purchased a new position in shares of Billiontoone during the 1st quarter worth approximately $29,179,000. Renaissance Technologies LLC purchased a new position in shares of Billiontoone in the 1st quarter valued at approximately $4,046,000. Emerald Advisers LLC boosted its position in shares of Billiontoone by 26.8% during the first quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock valued at $18,911,000 after purchasing an additional 50,613 shares in the last quarter. Catalio Capital Management LP bought a new stake in shares of Billiontoone during the fourth quarter valued at approximately $2,087,000. Finally, Public Employees Retirement System of Ohio bought a new stake in shares of Billiontoone during the first quarter valued at approximately $1,539,000.

About Billiontoone

(Get Free Report)

BillionToOne, Inc (NASDAQ:BLLN) is a molecular diagnostics company that develops blood-based genetic tests designed to provide more information from small amounts of cell-free DNA. The company’s platform uses proprietary molecular counting technology to improve the sensitivity and accuracy of diagnostic testing.

BillionToOne’s primary business is reproductive health testing. Its UNITY portfolio is designed to support prenatal screening, including testing for chromosomal conditions and single-gene disorders, and is intended to provide physicians and expectant parents with information from a maternal blood sample.

Recommended Stories

Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.